ArticleCardiovascular and interventional radiology2026
Access Vessel Patency After Endovascular Therapy via Tibiopedal Access in Patients With Lower Extremity Artery Disease.
Article in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the access vessel patency after endovascular therapy performed via tibiopedal access. MATERIALS AND
methodsThis was a retrospective, single-center, observational study. Patients who underwent endovascular therapy via tibiopedal access with sheath insertion were enrolled. The primary outcome was loss of access vessel patency defined as access vessel occlusion or stenosis with a peak systolic velocity ratio > 2.4 on duplex ultrasound at 6 months. Multivariate logistic regression analysis was performed to identify the predictors of access vessel patency loss, with hemodialysis, severely calcified access vessel and sheath-to-artery ratio included as covariates.
resultsA total of 95 limbs in 91 patients were included in this study, and loss of access vessel patency was observed in 22 limbs (23.1%). Multivariate logistic regression analysis demonstrated that sheath-to-artery ratio was the only independent predictor (odds ratio: 1.493, 95% confidence interval: 1.130-1.976; p = 0.005). The receiver operating characteristic curve analysis revealed that the optimal cutoff value of sheath-to-artery ratio for predicting loss of access vessel patency was 1.08, with an area under the curve of 0.723. In this cohort, the 2-year freedom from major adverse limb events were 98.6% (95% CI: 90.8-99.8%), and no major amputation occurred.
conclusionThe present study demonstrated a relatively high incidence of loss of access vessel patency after endovascular therapy via tibiopedal access, although this was not associated with an increase in major adverse limb events. A larger sheath-to-artery ratio was identified as an independent predictor of loss of access vessel patency.
Indexed as
Identifiers
42897321What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.